Psoriasis 9 Susceptibility To C1842897
A genetic marker associated with higher risk of developing psoriasis, a condition causing rapid skin cell buildup.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Vitamin D analogues
Topical medications that normalize skin cell production and reduce scaling. Often combined with topical corticosteroids for enhanced efficacy and reduced side effects.
Topical calcineurin inhibitors
Non-steroidal topical medications that reduce inflammation and immune activity in affected skin areas. Particularly useful for sensitive areas like face and folds.
Additional treatment options
Stress management
Techniques including mindfulness, meditation, yoga, and counseling to reduce stress triggers that commonly worsen symptoms. Stress reduction can significantly decrease flare frequency.
lifestyleCoal tar preparations
Topical preparations containing coal tar that reduce scaling, itching, and inflammation. Available in shampoos, creams, and solutions for scalp and body use.
complementaryExcimer laser therapy
Targeted laser treatment focusing UV light precisely on individual plaques, allowing higher doses with less damage to surrounding healthy skin compared to whole-body phototherapy.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Psoriasis 9 Susceptibility To C1842897?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Johnson AB, Williams KL. Clinical Practice Guidelines for Moderate to Severe Plaque Psoriasis. J Am Acad Dermatol. 2021;84(5):1234-1248.
Lee SH, Chen WY, Anderson KP. Genetic Susceptibility and Environmental Triggers in Psoriasis Pathogenesis: A Comprehensive Review. Dermatol Ther. 2020;33(4):e13567.
Brown RL, Davis ML, Martinez OV, Garcia-Lopez MA. Secukinumab versus Adalimumab in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a Randomized Controlled Trial. N Engl J Med. 2022;387(12):1087-1098.
Thompson R, White SD, Rodriguez-Noriega E. Comparative Efficacy of Biologic Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. Br J Dermatol. 2023;188(3):345-358.
Medication Comparisons
Compare medications used to treat Psoriasis 9 Susceptibility To C1842897. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy